BlackRock Fund Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
Other funds holding SPPI
BIT
BlackRock Fund Advisors's SPPI Position: Q4 2016 in Review
BlackRock Fund Advisors increased its Spectrum Pharmaceuticals Inc (SPPI) stake by 15% in Q4 2016, buying an estimated $4.64M and bringing the position to 8,524,295 shares worth $37.8M. The position accounts for 0.01% of the portfolio, ranked #1841.
BlackRock Fund Advisors first reported a position in SPPI in Q2 2013 and has held it in 15 quarters since. The position peaked at $41M in Q2 2015. 139 funds tracked by Wall St. Rank hold SPPI as of Q4 2016.
- BlackRock Fund Advisors held 8,524,295 shares of Spectrum Pharmaceuticals Inc worth $37.8M as of Q4 2016.
- BlackRock Fund Advisors bought 1,106,467 Spectrum Pharmaceuticals Inc shares in Q4 2016, an estimated $4.64M.
- Spectrum Pharmaceuticals Inc made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1841 holding.
- BlackRock Fund Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
- BlackRock Fund Advisors's Spectrum Pharmaceuticals Inc position peaked at $41M in Q2 2015.
- 139 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2016.
Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.